M. Bellei

发表

Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone

N. Kneer, H. Lardy, V. Bobyleva, 1993, Journal of bioenergetics and biomembranes.

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial Running head Baseline metabolic tumor volume and early response in HL Authors

J. Raemaekers, O. Casasnovas, M. Federico, 2018 .

High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.

M. Federico, C. Gisselbrecht, A. Nagler, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy: long-term results

P. Feugier, M. Federico, C. Gisselbrecht, 2009, Haematologica.

Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.

P. Gobbi, A. Levis, T. Chisesi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose T herapy a nd A utologous S tem-Cell T ransplantation Versus C onventional T herapy f or P atients W ith A dvanced Hodgkin's L ymphoma R esponding t o F ront-Line T herapy

M. Federico, C. Gisselbrecht, A. Nagler, 2003 .

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

E. Iannitto, M. Federico, C. Tripodo, 2018, British journal of haematology.

High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study

A. López-Guillermo, F. Cavalli, A. Rossi, 2011, Leukemia & lymphoma.

Induction of Thermogenic Enzymes by DHEA and Its Metabolites

N. Kneer, H. Lardy, V. Bobyleva, 1995, Annals of the New York Academy of Sciences.

Sources of intramitochondrial malate

H. Lardy, V. Bobyleva-Guarriero, M. Bellei, 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Long Term Follow-up Analysis of HD9601 Trial Comparing ABVD Vs Stanford V Vs MOPPABVCAD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma. A Study from the Intergruppo Italiano Linfomi (IIL)

P. Gobbi, A. Levis, T. Chisesi, 2008 .

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas

R. Advani, S. Montoto, M. Federico, 2019, American journal of hematology.

Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

M. Federico, M. André, A. Versari, 2016 .

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

J. Raemaekers, M. Federico, C. Sebban, 2012 .

Follicular lymphoma - treatment and prognostic factors

M. Federico, S. Luminari, M. Bellei, 2012, Revista brasileira de hematologia e hemoterapia.

When should a watch-and-wait strategy be adopted for follicular lymphoma?

P. Solal-Céligny, M. Bellei, 2013 .

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

A. Stamatoullas, M. Federico, L. Specht, 2017 .

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

G. Salles, E. Campo, F. Cavalli, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interaction of cartinine with mitochondrial cardiolipin

U. Muscatello, E. Arrigoni-Martelli, M. Bellei, 1992 .

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Martin Hutchings, Annibale Versari, Umberto Ricardi, 2018, Blood.

The protecting effect of L‐carnitine on Ca2+‐loaded rat liver mitochondria

A. Starkov, V. Bobyleva, U. Muscatello, 1991, FEBS letters.

Comparative studies of effects of dehydroepiandrosterone on rat and chicken liver.

N. Kneer, H. Lardy, V. Bobyleva, 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

R. Advani, S. Montoto, M. Federico, 2018, Haematologica.

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

M. Federico, A. Maiorana, M. Salati, 2015, Hematological oncology.

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.

E. Iannitto, M. Federico, M. Martelli, 2004, Blood.

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project

M. Federico, M. Bellei, 2019, Haematologica.

Prognostic factors in low-grade non-Hodgkin lymphomas

S. Molica, M. Federico, S. Luminari, 2009, Current Hematologic Malignancy Reports.

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

O. Casasnovas, P. Gobbi, E. Iannitto, 2020, Cancer medicine.

Peripheral T cell lymphoma , not otherwise specified ( PTCL-NOS ) . A new prognostic model developed by the International T cell Project Network

R. Advani, J. Vose, S. Montoto, 2022 .

patients at high risk of relapse candidates for intensifica- tion with HDT and ASCT.

C. Gisselbrecht, P. Brice, G. Visani, 2009 .

Pitfalls and major issues in the histologic diagnosis of peripheral T‐cell lymphomas: results of the central review of 573 cases from the T‐Cell Project, an international, cooperative study

D. Weisenburger, J. Vose, S. Pileri, 2017, Hematological oncology.

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

J. Vose, S. Pileri, M. Federico, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database.

S. Montoto, L. Gordon, S. Pileri, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Giovanni Martinelli, Stefano Luminari, Luigi Rigacci, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project

J. Vose, M. Federico, C. Nabhan, 2015, Current Hematologic Malignancy Reports.

T-Cell Lymphomas in South America and Europe

J. Vose, S. Montoto, J. Connors, 2012, Revista brasileira de hematologia e hemoterapia.

Projeto de célula-T: estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo

D. Weisenburger, J. Vose, S. Montoto, 2009 .

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

B. Nathwani, D. Weisenburger, J. Armitage, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

J. Sancho, M. Federico, M. Ramírez, 2022, Haematologica.

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.

J. Vose, J. Radford, M. Federico, 2021, Blood advances.